Cardiovascular Disease

ne of the most significant present discussions on Mental Health is the physical health of people with severe Mental illness (SMI). It is getting increasing difficult to dismiss due to years of neglect, which, as a result, has a negative impact on a patient with SMI. The main issues addressed in this essay are the learning out (LO 1, 2, 3 and 4).
These can, only be met by critically analyzing; the following (see Appendix 1). This essay is about a mental health patient with co-mobility of schizophrenia with cardiovascular disease (CVD). However, for the purpose of this essay the author will focus on the physical health of the patient, which is cardiovascular disease and also explore the following aspect of the disease. E.g pathophysiology, homeostasis,

al, 2009 c). CVD is also associated with secondary aging, with a progressive decline in numerous physiological processes, resulting in an increased risk of health complications and disease (North & Sinclair, 2012 a). The health of the cardiovascular system is vital for the health of every tissue, aging have a significant effect on the heart and arterial system, resulting in CVD (North & Sinclair, 2012 b). Both the heart and vasculature undergo numerous alterations during aging as a result of deregulation of molecular longevity pathways leading to compromised function (Fleg et al., 2013, North & Sinclair, 2012 c). Consequently, there are physical changes in John, caused by homeostasis imbalance due to the effects of aging. This is making John, to have fatigue, shortness of breath, high heart rate, high blood pressure, and as a result affect his activities of daily living. In agreement with this, Boundless (2015) Carter (2017) suggests that homeostatic is the source of imbalance and it’s also responsible for the physical changes associated with aging. The pathophysiology of cardiovascular disease in heart failure, is closely related to the abnormalities in cardiovascular reflexes. There are two cardiovascular reflexes s abnormalities that go on during heart failure. The sympatho-inhibitory cardiovascular

This medication is prescribed for its inhibitors such as platelet adhesion, platelet activation, platelet aggregation and platelet mediated links with inflammation (Espinosa et al. 2011). Although it has a fewer side effects, and it may not be effective. So if CVD is severe a different medication or combination of medications may be required (Fisher, 2009). However, there are several side effects associated with the use of Aspirin, these include indigestion and increased risk of bleeding. The other rarer side effect is gastrointestinal discomfort, nausea, tinnitus, headache, vertigo, hives and bruising. Patients are often prescribed proton pump inhibitors (PPIs) such as Lansoprazole to prevent some of the gastrointestinal side effect (Cunha & Anand, 2015). The alternative medication for patients that are Intolerance/hypersensitivity to Aspirin, is Clopidogrel this drug inhibits the platelets, but doesn't affect the cyclooxygenase (Society et al., 2005, Nice, 2015).
Furthermore, CVD can be treated/control with therapeutic interventions such as, keeping the daily dietary fat intake to the minimum, low salt, combined omega-3 fatty acids,’ this may keep CVD in control, within normal range of blood pressure, BMI, and serum lipids (Watson & Preedy, 2012). There is scientific evidence